Key points are not available for this paper at this time.
Though concerns about a potential conflict of interest remain paramount and must be addressed in any new system of reimbursement, oncologists believe reimbursement to enhance infrastructure could help overcome barriers to trial accrual.
Lee et al. (Fri,) studied this question.